244 related articles for article (PubMed ID: 33020179)
1. Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.
Oba T; Saito T; Asada A; Shimizu S; Iijima KM; Ando K
J Biol Chem; 2020 Dec; 295(50):17138-17147. PubMed ID: 33020179
[TBL] [Abstract][Full Text] [Related]
2. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
[TBL] [Abstract][Full Text] [Related]
3. Microtubule-affinity regulating kinase family members distinctively affect tau phosphorylation and promote its toxicity in a Drosophila model.
Sultanakhmetov G; Kato I; Asada A; Saito T; Ando K
Genes Cells; 2024 Apr; 29(4):337-346. PubMed ID: 38329182
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment.
Sun W; Lee S; Huang X; Liu S; Inayathullah M; Kim KM; Tang H; Ashford JW; Rajadas J
Sci Rep; 2016 Oct; 6():34784. PubMed ID: 27708431
[TBL] [Abstract][Full Text] [Related]
5. MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.
Lund H; Gustafsson E; Svensson A; Nilsson M; Berg M; Sunnemark D; von Euler G
Acta Neuropathol Commun; 2014 Feb; 2():22. PubMed ID: 24533944
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.
Chatterjee S; Sang TK; Lawless GM; Jackson GR
Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955
[TBL] [Abstract][Full Text] [Related]
7. Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1.
Iijima-Ando K; Sekiya M; Maruko-Otake A; Ohtake Y; Suzuki E; Lu B; Iijima KM
PLoS Genet; 2012; 8(8):e1002918. PubMed ID: 22952452
[TBL] [Abstract][Full Text] [Related]
8. Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease.
Iijima K; Gatt A; Iijima-Ando K
Hum Mol Genet; 2010 Aug; 19(15):2947-57. PubMed ID: 20466736
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.
Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM
PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670
[TBL] [Abstract][Full Text] [Related]
10. A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration.
Iijima-Ando K; Zhao L; Gatt A; Shenton C; Iijima K
Hum Mol Genet; 2010 May; 19(10):1930-8. PubMed ID: 20159774
[TBL] [Abstract][Full Text] [Related]
11. A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity.
Oba T; Homma D; Limlingan SJM; Fukuchi A; Asada A; Saito T; Ando K
Neurobiol Dis; 2023 Nov; 188():106334. PubMed ID: 37884211
[TBL] [Abstract][Full Text] [Related]
12. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.
Trinczek B; Brajenovic M; Ebneth A; Drewes G
J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945
[TBL] [Abstract][Full Text] [Related]
13. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease.
Gu GJ; Wu D; Lund H; Sunnemark D; Kvist AJ; Milner R; Eckersley S; Nilsson LN; Agerman K; Landegren U; Kamali-Moghaddam M
J Alzheimers Dis; 2013; 33(3):699-713. PubMed ID: 23001711
[TBL] [Abstract][Full Text] [Related]
14. Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.
Gu GJ; Lund H; Wu D; Blokzijl A; Classon C; von Euler G; Landegren U; Sunnemark D; Kamali-Moghaddam M
Neuromolecular Med; 2013 Sep; 15(3):458-69. PubMed ID: 23666762
[TBL] [Abstract][Full Text] [Related]
15. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
16. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
17. Ca2+/calmodulin-dependent protein kinase II promotes neurodegeneration caused by tau phosphorylated at Ser262/356 in a transgenic Drosophila model of tauopathy.
Oka M; Fujisaki N; Maruko-Otake A; Ohtake Y; Shimizu S; Saito T; Hisanaga SI; Iijima KM; Ando K
J Biochem; 2017 Nov; 162(5):335-342. PubMed ID: 28992057
[TBL] [Abstract][Full Text] [Related]
18.
Sultanakhmetov G; Limlingan SJM; Fukuchi A; Tsuda K; Suzuki H; Kato I; Saito T; Weitemier AZ; Ando K
Brain Commun; 2024; 6(3):fcae136. PubMed ID: 38712317
[TBL] [Abstract][Full Text] [Related]
19. An identification of MARK inhibitors using high throughput MALDI-TOF mass spectrometry.
Hruba L; Polishchuk P; Das V; Hajduch M; Dzubak P
Biomed Pharmacother; 2022 Feb; 146():112549. PubMed ID: 34923338
[TBL] [Abstract][Full Text] [Related]
20. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.
Paudel HK; Lew J; Ali Z; Wang JH
J Biol Chem; 1993 Nov; 268(31):23512-8. PubMed ID: 8226879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
